Tips en venn



Send tips til:
(Bruk komma mellom flere adresser)

Din e-post adresse:

Din kommentar:

Tips en venn om denne portalen »
Om oss » Retningslinjer » Kontakt redaksjonen »
TIPS en venn »

Fokus > Genome

Burgers and Flies

Inspired by Darwin, Mohamed Noor has uncovered the molecular dance by which a single species becomes two.

(The Scientist)
[21.05.2012 15:41]

Les mer »
Annonse:
Genetic Testing May Not Drive Up Health Costs

Having the results of a personalized genetic test did not drive patients to utilize potentially costly follow-up healthcare services, a study from the National Institutes of Health (NIH) found.

(MedPage Today)
[18.05.2012 23:01]

Les mer »
Nvidia tries to link cloud with graphics processors

Nvidia on Tuesday announced technologies that could make its upcoming Tesla graphics processors more accessible to cloud deployments in enterprises, while also reversing a trend of relegating highly parallel chips to specialized math and scientific calculations.

(IDG / no Alt om IT)
[15.05.2012 22:29]

Les mer »
Annonse:
JP Morgan losses cause market nerves

Volatile day of trading sees retailers making decent gains, but banks suffer as Spain unveils plans to reform sector

(The Guardian Oil)
[11.05.2012 20:49]

Les mer »
GlaxoSmithKline turns up the heat on Human Genome Sciences

it would be understandable if HGS shareholders feel GSK, after 20 years of collaboration with HGS, is forcing the pace for a reason

(The Guardian Oil)
[09.05.2012 20:52]

Les mer »
Whole-genome sequence data for selective breeding against infectious diseases in aquaculture

Project aim: to develop methodology to utilise whole-genome sequence data for selective breeding against infectious diseases in aquaculture

(UMB)
[09.05.2012 18:08]

Les mer »
Exome sequencing in Atlantic salmon

The main goal of this proposal is to exploit the forthcoming reference genome sequence, together with the wealth of transcriptome data, to develop a whole genome exon capture array for Atlantic salmon ( Salmo salar ).

(UMB)
[09.05.2012 17:52]

Les mer »
GlaxoSmithKline steps up hostile bid for Human Genome Sciences

Drugmaker takes bid directly to shareholders with tender offer at $13 a share for US biotech company

(The Guardian Oil)
[09.05.2012 14:21]

Les mer »
GlaxoSmithKline launches hostile $2.6bn bid for US group Human Genome

Company takes its offer direct to shareholders after bid is rejected as being too low

(The Guardian Oil)
[09.05.2012 13:12]

Les mer »
Glaxo vil kuppe konkurrent

GlaxoSmithKline (GSK) vil fremlegge et fiendtlig bud på Human Genome Sciences på 13 dollar pr aksje i stedet for å delta i dets strategiske gjennomgangsprosess. Det opplyses i en melding onsdag.

(Dagens Næringsliv)
[09.05.2012 09:40]

Les mer »
Genes and the Human Brain Evolution

(Ivanhoe Newswire)— The human brain is the center of the human nervous system and has the same general structure as the brains of other mammals, but it’s than expected.

(Medical Breakthroughs)
[09.05.2012 05:18]

Les mer »
Expanding the technology base for Norwegian wheat breeding; Sequencing wheat chromosome 7B.

This project represents the first Norwegian participation in an international genomics program for agricultural plants.

(UMB)
[08.05.2012 10:46]

Les mer »
08/05-2012 09:40:17: ( DIAG ) DiaGenic reports completion of data collection and genetic analyses in a unique study on familial Parkinson's disease Oslo - May 8th 2012 (DiaGenic ASA [OSL:DIAG]): DiaGenic today reports on the finalization of data collection and database lock of a blinded study in a Norwegian cohort of 80 patients with familial Parkinson's disease (PD). The majority of these patients are carrying a mutation in the parkin 8 gene (also called LRRK2) that significantly increases the risk of developing PD. Patients recruited from St Olavs University Hospital under the lead of Principal Investigator Professor Jan Aasly are all LRRK2 mutation carriers with or without the disease or healthy relatives. Unblinding of the study is set to the May 16th and analysis and reporting is expected to be completed during summer 2012. As part of the overarching program on development of diagnostic biomarkers for PD, the objective of the study is to identify a biomarker for individuals at risk of developing the disease using material from LRRK2 individuals and relatives. The LRRK2 study is unique being the first blood based RNA analysis in pre symptomatic PD. The study is also expected to allow independent validation of DiaGenic's European multicentre study that previously this year reported a high accuracy (88%) in PD patients reported February 8th 2012. The collection of data from the Norwegian individuals with this rare mutation has been ongoing at St. Olav`s University Hospital in Trondheim, Norway, since 2009 and includes collection of blood for gene signature analysis, clinical variables and imaging of the brain. By taking blood samples from individuals with LRRK2 mutations and identifying a gene signature before signs of the disease occur, a general blood based diagnostic test for early PD can be developed.

(Netfonds)
[08.05.2012 09:53]

Les mer »
Genetics Could Predict Relapse of Prostate Cancer

(Ivanhoe Newswire) -- Monitoring PSA levels in men over 50 has greatly improved early detection of prostate cancer, but prediction of clinical outcomes after diagnosis remains a major challenge.

(Medical Breakthroughs)
[07.05.2012 05:22]

Les mer »
Viddi.no™ - best på lokale søk.
|Om Viddi.no | Kontakt oss på support (a) viddi.no | Copyright® - 2006 Viddinews AS |